NASDAQ$HYFM

Hydrofarm Holdings Group Inc. · Q3 2025 earnings

Q3 2025 earnings · · Before market open · Investor relations

Briefing

HYFM reported Q3 2025 revenue of $29.4M, a net loss of $16.4M.

For Q3 2025, HYFM reported Revenue was $29.4M, net loss was $16.4M. The filing discusses operating performance, liquidity, and outlook in MD&A.

  • Revenue $29.4M for Q3 2025.
  • Net loss $16.4M.
  • MD&A covers R&D, cash runway, and sector-specific risks.

Headline financials

Total Revenue

$29.4M

Previous: $44M-33.3%
EPS (adj)

-$3.51

Previous: -$0.29-1110.3%
Adjusted gross profit margin

18.8%

Previous: 24.3%-22.6%
Adjusted EBITDA

-$4.38M

Previous: $20K-21990.0%
SG&A expenses

$16.4M

Previous: $17.6M-6.8%
Adjusted SG&A

$9.89M

Previous: $10.7M-7.4%
SG&A as % of sales

55.8%

Previous: 39.9%+39.8%
Adjusted SG&A as % of sales

33.7%

Previous: 24.3%+38.7%
Net loss as % of sales

-55.8%

Previous: -29.9%-86.6%
Adjusted EBITDA margin

-14.9%

Previous: 0.0%
Gross Margin

11.6%

Previous: 19.4%-40.2%
Capital Expenditures

-$695K

Previous: -$2.62M+73.5%
Net Income

-$16.4M

Previous: -$13.1M-24.7%
Operating Income

-$13M

Previous: -$9.04M-43.4%
Gross Profit

$3.41M

Previous: $8.52M-60.0%

Revenue & EPS history

Hydrofarm · Revenue · Quarterly

$29.4M

Q3 2025-33.3%vs Q3 2024
Beat estimate in 7 of 13 quarters(54%)
ActualEstimate

Forward guidance

Outlook focuses on cash runway, pipeline milestones, and cost discipline as the company works toward profitability.

Tailwinds

  • Cash and equivalents support operations into upcoming milestones.
  • Clinical or product pipeline progress noted in MD&A.

Headwinds

  • Ongoing operating losses and R&D spend pressure near-term earnings.
  • Financing, dilution, or partnership timing may affect liquidity.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-2.6%

Avg return

Earnings day

-4.3%

Avg return

5 days after

-7.5%

Avg return

30 days after

38%

10 / 26 earnings

Positive

+16.2%

Q4 2020

Best reaction

-22.7%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025-0.9%-1.8%
Q1 2026-6.5%-10.3%-13.8%
Q3 2025-14.6%-21.9%-3.0%
Q2 2025-2.9%+0.0%-28.4%
Q1 2025+8.0%-1.9%-0.9%
Q4 2024-20.9%-26.8%-61.2%
Q3 2024-4.9%-2.7%+13.8%
Q2 2024+1.9%+0.0%+14.4%
Q1 2024-3.7%-10.2%-14.2%
Q4 2023+7.0%-2.1%+25.6%
Q3 2023+4.4%+0.0%+25.9%
Q2 2023-22.7%-22.4%-4.0%
Q1 2023-8.7%-15.0%-22.6%
Q4 2022+15.9%+18.5%-6.0%
Q3 2022+8.2%+19.7%-1.7%
Q2 2022+14.2%+30.5%+2.7%
Q1 2022-20.8%+1.9%-34.3%
Q4 2021-14.9%-28.5%-25.2%
Q4 2019-14.9%-28.5%-25.2%
Q3 2020-1.4%-10.7%-40.4%
Q3 2021+12.3%+10.8%-28.2%
Q2 2020-11.7%-8.2%+12.1%
Q2 2021-5.6%-16.6%+5.7%
Q1 2020+4.1%+3.3%+0.3%
Q1 2021-3.6%-0.3%-4.7%
Q4 2020+16.2%+10.8%+26.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro